Demand for sterile medical packaging products is projected to reach $6.5 billion in 2012, as per a report by reportlinker.com. Growth will be driven by the shift to an older demographic, which will lead to a rising incidence of acute and chronic conditions and an increasing volume of patient activity. Upward trends in patient activity will broaden the overall use of sterile medical products, impacting favorably on demand for related packaging. In addition to greater patient activity, the sterile medical packaging market will benefit from ongoing new product introductions and the upgrading of health care infection prevention standards.
Advancing medical technologies are expanding the market for sterile medical packaging by leading to the introduction of new end-use products. Virtually all biotechnology-based pharmaceuticals, biologicals and diagnostic substances are contaminant-vulnerable compounds that must be stored and dispensed under sterile conditions. Moreover, many of the new medical devices reaching the commercial stage are implantable or direct contact products composed of sterile biocompatible components.
10-Oct-08 
{{comment.DateTimeStampDisplay}}
{{comment.Comments}}